Literature DB >> 10845423

Accelerated development of polyoma tumors and embryonic lethality: different effects of p53 loss on related mouse backgrounds.

D C Dey1, R P Bronson, J Dahl, J P Carroll, T L Benjamin.   

Abstract

Molecular evidence linking polyoma virus to p53 inactivation is thus far lacking, setting this highly oncogenic virus apart from other DNA tumor viruses. As a biological test for interaction, we studied the effects of p53 loss on development of virus-induced tumors. The absence of p53 led to more rapid tumor development on two different mouse backgrounds, indicating synergism between p53 loss and oncogenic pathways controlled directly by the virus. No effects of p53 on tumor type or frequency were noted. Polyoma tumor-derived cells in culture retained p53, and most of these showed induction of p21CIP1/WAF1 in response to DNA damage. These results indicate that p53 functions are not directly and fully impaired by the virus in the intact host. On one mouse background, it was discovered that loss of p53 resulted in complete embryonic lethality prior to 11 days of gestation. This lethality could be rescued by inclusion of gene(s) from a 129/SvJ background.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10845423

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  13 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  Induction and utilization of an ATM signaling pathway by polyomavirus.

Authors:  Jean Dahl; John You; Thomas L Benjamin
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 3.  Transcriptional control of terminal nephron differentiation.

Authors:  Samir S El-Dahr; Karam Aboudehen; Zubaida Saifudeen
Journal:  Am J Physiol Renal Physiol       Date:  2008-02-20

4.  A tumor host range selection procedure identifies p150(sal2) as a target of polyoma virus large T antigen.

Authors:  D Li; K Dower; Y Ma; Y Tian; T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-04       Impact factor: 11.205

5.  Activation of CREB/ATF sites by polyomavirus large T antigen.

Authors:  Tara M Love; Rowena de Jesus; Jennifer A Kean; Qing Sheng; Andrew Leger; Brian Schaffhausen
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  Promoter methylation of the SALL2 tumor suppressor gene in ovarian cancers.

Authors:  Chang K Sung; Dawei Li; Erik Andrews; Ronny Drapkin; Thomas Benjamin
Journal:  Mol Oncol       Date:  2012-12-12       Impact factor: 6.603

Review 7.  The MDM2-p53 pathway: multiple roles in kidney development.

Authors:  Samir El-Dahr; Sylvia Hilliard; Karam Aboudehen; Zubaida Saifudeen
Journal:  Pediatr Nephrol       Date:  2014-04       Impact factor: 3.714

8.  p150(Sal2) is a p53-independent regulator of p21(WAF1/CIP).

Authors:  Dawei Li; Yu Tian; Yupo Ma; Thomas Benjamin
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

9.  Susceptibility to polyomavirus-induced tumors in inbred mice: role of innate immune responses.

Authors:  Palanivel Velupillai; John P Carroll; Thomas L Benjamin
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Polyoma virus-induced osteosarcomas in inbred strains of mice: host determinants of metastasis.

Authors:  Palanivel Velupillai; Chang Kyoo Sung; Yu Tian; Jean Dahl; John Carroll; Roderick Bronson; Thomas Benjamin
Journal:  PLoS Pathog       Date:  2010-01-22       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.